What is he best known for?
The fields of study he is best known for:
Benjamin J. Doranz mainly focuses on Virology, Chemokine receptor, Coreceptor activity, Chemokine receptor CCR5 and Receptor.
His study of Virus is a part of Virology.
While the research belongs to areas of Virus, Benjamin J. Doranz spends his time largely on the problem of T cell, intersecting his research to questions surrounding CXCR4.
His biological study spans a wide range of topics, including Chemokine Receptor Gene, Lipid bilayer fusion and Null allele.
His Chemokine Receptor Gene research is multidisciplinary, incorporating elements of Allele and Allele frequency.
His Receptor research incorporates themes from Simian immunodeficiency virus and Cell biology.
His most cited work include:
- Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. (2552 citations)
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors (1813 citations)
- Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver (632 citations)
What are the main themes of his work throughout his whole career to date?
Virology, Epitope, Antibody, Monoclonal antibody and Virus are his primary areas of study.
In his work, Simian immunodeficiency virus is strongly intertwined with Chemokine receptor, which is a subfield of Virology.
Benjamin J. Doranz combines subjects such as Molecular biology, Glycoprotein and Ebolavirus with his study of Epitope.
His Antibody study integrates concerns from other disciplines, such as G protein-coupled receptor, Flavivirus and Hepatitis C virus.
He interconnects Mutagenesis, Alphavirus, Computational biology and Zika virus in the investigation of issues within Monoclonal antibody.
His Virus research is multidisciplinary, relying on both T cell and CXCR4.
He most often published in these fields:
- Virology (57.43%)
- Epitope (43.24%)
- Antibody (41.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Antibody (41.22%)
- Virology (57.43%)
- Epitope (43.24%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Antibody, Virology, Epitope, Monoclonal antibody and Neutralization.
His study in Antibody is interdisciplinary in nature, drawing from both Biochemistry, Computational biology, Immune system and In vivo.
His work in Virology covers topics such as B cell which are related to areas like Transcriptome.
The study incorporates disciplines such as In vitro, Neutralizing antibody, Ebola virus, Somatic hypermutation and Glycoprotein in addition to Epitope.
His Monoclonal antibody research incorporates themes from Cell, G protein-coupled receptor, Humoral immunity, Antigen and Mutagenesis.
His Virus research integrates issues from Protein domain and Recombinant DNA.
Between 2018 and 2021, his most popular works were:
- Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. (28 citations)
- Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. (27 citations)
- Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. (26 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Virology, Antibody, Epitope, Monoclonal antibody and Neutralization.
His Virology study deals with Antigen intersecting with Viral envelope.
His Antibody research incorporates elements of Vero cell, In vitro, Plasma protein binding, Mutation and Protein folding.
In his study, Epitope mapping, Antibody Repertoire and Molecular mimicry is strongly linked to Ebola virus, which falls under the umbrella field of Epitope.
His Receptor research extends to Monoclonal antibody, which is thematically connected.
His work focuses on many connections between Virus and other disciplines, such as Recombinant DNA, that overlap with his field of interest in Mutagenesis, Enzyme and Protein domain.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
